Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice.
Hypoxia-inducible factor-1α
Liver cancer
Macrophage
Journal
Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
06
09
2018
revised:
12
03
2019
accepted:
15
03
2019
pubmed:
22
3
2019
medline:
14
4
2020
entrez:
22
3
2019
Statut:
ppublish
Résumé
Chronic inflammation of the liver is often observed with obesity or type 2 diabetes. In these pathological conditions, the immunological cells, such as macrophages, play important roles in the development or growth of liver cancer. Recently, it was reported that hypoxia-inducible factor-1α (HIF-1α) is a key molecule for the acquisition of inflammatory M1 polarity of macrophages. In the present study, we examined the effects of altered macrophage polarity on obesity- and diabetes-associated liver cancer using macrophage-specific HIF-1α knockout (KO) mice. To induce liver cancer in the mice, diethylnitrosamine, a chemical carcinogen, was used. Both KO mice and wild-type littermates were fed either a high-fat diet (HFD) or normal chow. They were mainly analyzed 6 months after HFD feeding. Development of liver cancer after HFD feeding was 45% less in KO mice than in wild-type littermates mice. Phosphorylation of extracellular signal-regulated kinase 2 was also lower in the liver of KO mice. Those effects of HIF-1α deletion in macrophages were not observed in normal chow-fed mice. Furthermore, the size of liver tumors did not differ between KO and wild-type littermates mice, even those on a HFD. These results suggest that the activation of macrophage HIF-1α by HFD is involved not in the growth, but in the development of liver cancer with the enhanced oncogenic extracellular signal-regulated kinase 2 signaling in hepatocytes. The activation of macrophage HIF-1α might play important roles in the development of liver cancer associated with diet-induced obesity and diabetes.
Identifiants
pubmed: 30897274
doi: 10.1111/jdi.13047
pmc: PMC6825928
doi:
Substances chimiques
Hif1a protein, mouse
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1411-1418Subventions
Organisme : Japan Society for the Promotion of Science
ID : 17K16143
Organisme : Japan Society for the Promotion of Science
ID : 25461333
Organisme : Japan Society for the Promotion of Science
ID : 26461327
Organisme : Japan Foundation for Applied Enzymology
Informations de copyright
© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Références
J Diabetes Investig. 2019 Nov;10(6):1411-1418
pubmed: 30897274
Oncogene. 2011 Apr 28;30(17):1969-83
pubmed: 21258404
Cancer Cell. 2013 Mar 18;23(3):277-86
pubmed: 23518347
J Cancer Res Clin Oncol. 2000 Jan;126(1):57-61
pubmed: 10641751
Cell Metab. 2016 Jan 12;23(1):48-62
pubmed: 26771116
Genes Dev. 2010 Mar 1;24(5):491-501
pubmed: 20194441
Oncotarget. 2016 May 24;7(21):30951-61
pubmed: 27129159
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
N Engl J Med. 2008 Nov 6;359(19):1995-2004
pubmed: 18923165
Arch Pathol Lab Med. 2000 Jul;124(7):1061-5
pubmed: 10888784
Trends Biochem Sci. 1999 Feb;24(2):68-72
pubmed: 10098401
Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103
pubmed: 15508109
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
J Hepatol. 2015 Mar;62(3):607-16
pubmed: 25450711
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nat Commun. 2017 Aug 18;8(1):286
pubmed: 28819169
Biochem Biophys Res Commun. 2011 Nov 25;415(3):445-9
pubmed: 22051049
Sci Rep. 2017 Jun 20;7(1):3855
pubmed: 28634350
Cancer Prev Res (Phila). 2011 Mar;4(3):396-403
pubmed: 21372039
J Hepatol. 1997 Nov;27(5):854-61
pubmed: 9382973
Hepatology. 2002 Jul;36(1):150-5
pubmed: 12085359
JAMA. 2008 Jan 2;299(1):53-60
pubmed: 18167406
J Gastroenterol. 2017 Jan;52(1):26-38
pubmed: 27714455
Hepatology. 2004 Jun;39(6):1517-24
pubmed: 15185292
Front Med. 2014 Mar;8(1):33-41
pubmed: 24234682
Cell Rep. 2017 Aug 15;20(7):1654-1666
pubmed: 28813676
Diabetes. 2009 Nov;58(11):2574-82
pubmed: 19690061
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Int J Cancer. 2011 Mar 15;128(6):1259-68
pubmed: 20506153
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Diabetes. 2016 Dec;65(12):3649-3659
pubmed: 27625023
Diabetologia. 2013 Jun;56(6):1403-12
pubmed: 23494472
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760